It has been suggested that nesfatin-1 can improve insulin sensitivity and glucose uptake in muscle and AT while reducing hepatic glucose production and lipid accumulation, which can help prevent the development of IR and metabolic disorders, such as T2D (Figure 1) [58]. The gene discussed is NUCB2; the disease is Other metabolic disease.